CPIM
REGN icon

Columbia Partners Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Columbia Partners Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,365
Closed -$1.64M – 239
2017
Q4 		$1.64M Sell
4,365
-3,756
-46% -$1.52M 0.22% 130
2017
Q3 		$3.63M Buy
+8,121
New +$3.86M 0.48% 64
2017
Q2 		– Sell
-4,599
Closed -$1.78M – 265
2017
Q1 		$1.78M Sell
4,599
-660
-13% -$245K 0.23% 125
2016
Q4 		$1.93M Sell
5,259
-5,773
-52% -$2.2M 0.17% 177
2016
Q3 		$4.43M Buy
+11,032
New +$4.43M 0.35% 106
2016
Q2 		– Sell
-17,324
Closed -$6.24M – 361
2016
Q1 		$6.24M Sell
17,324
-6,157
-26% -$2.54M 0.45% 77
2015
Q4 		$12.7M Buy
23,481
+106
+0.5% +$57.4K 0.88% 22
2015
Q3 		$10.9M Sell
23,375
-487
-2% -$262K 0.76% 31
2015
Q2 		$12.2M Sell
23,862
-4,627
-16% -$2.26M 0.75% 30
2015
Q1 		$12.9M Sell
28,489
-1,058
-4% -$448K 0.68% 41
2014
Q4 		$12.1M Sell
29,547
-622
-2% -$245K 0.63% 50
2014
Q3 		$10.9M Sell
30,169
-492
-2% -$165K 0.55% 58
2014
Q2 		$8.66M Sell
30,661
-373
-1% -$111K 0.4% 90
2014
Q1 		$9.32M Sell
31,034
-81
-0.3% -$25K 0.41% 85
2013
Q4 		$8.56M Sell
31,115
-295
-0.9% -$84.8K 0.37% 101
2013
Q3 		$9.83M Sell
31,410
-617
-2% -$162K 0.44% 72
2013
Q2 		$7.2M Buy
+32,027
New +$7.46M 0.34% 108

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Columbia Partners Investment Management's REGN Position: Q1 2018 in Review

Columbia Partners Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q1 2018, closing a stake of 4,365 shares — an estimated $1.64M sold.

Columbia Partners Investment Management first reported a position in REGN in Q2 2013 and held it in 17 quarters. The position peaked at $12.9M in Q1 2015. 620 funds tracked by Wall St. Rank hold REGN as of Q1 2018.

  • Columbia Partners Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Columbia Partners Investment Management sold 4,365 Regeneron Pharmaceuticals shares in Q1 2018, an estimated $1.64M.
  • Columbia Partners Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Columbia Partners Investment Management's Regeneron Pharmaceuticals position peaked at $12.9M in Q1 2015.
  • 620 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2018.

Based on Columbia Partners Investment Management's 13F filing for Q1 2018, filed 15 May 2018.